Fortress Biotech Reports Record First Quarter 2020 Financial Results and Recent Corporate Highlights
First quarter 2020 product revenue increased 95% year-over-year to $11.9 million NDA for IV tramadol accepted for review by FDA; assigned PDUFA date of October 10, 2020 Agreement executed with Columbia University to develop a broad platform technology to …